Metastatic triple-negative breast cancer (mTNBC), defined as lack of estrogen receptor (ER), progression receptor (PR), and human epidermal growth factor receptor 2 (HER2) overexpression, remains a disease of unmet need. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.